Revlimid® Capsules Special Drug Use-results Survey (in Patients With Newly-diagnosed Multiple Myeloma [NDMM])

NCT02741544 · clinicaltrials.gov ↗
COMPLETED
Status
578
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Celgene